Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Manuscript submission

It is requested that solicited manuscripts are submitted on or before the deadline agreed with the journal Editor. If the manuscript under preparation requires authorisation by your organisation prior to submission, please take this into account when working towards these deadlines.

If you are submitting a solicited manuscript, please submit your article directly to the journal Editor by email. For unsolicited articles, please submit your article to the Editor at submitcp@rpharms.com, along with a cover letter detailing and outlining your submission in context of the journal’s aims and scope.

Where possible, manuscripts should be submitted in Microsoft Word or an editable file format and, to help with the speed of processing of manuscripts, authors should ensure that their manuscript has been edited for language and grammar by a fluent English speaker prior to submission. Pharmaceutical Journal Publications do not currently offer a language editing service, however this can be facilitated (with prior discussion with the Editor) at a charge. Please contact the Editor for more information.

Peer Review

Once a manuscript has been received by the Editor, it will then be peer-reviewed (this process usually takes three to four weeks). Authors are requested to submit a list of suitable peer reviewers with their article submission, in order to aid this process.

Revision

Once the manuscript has been peer-reviewed, a further two weeks is allowed for any revisions (as suggested by the reviewers/Editor) to be made.

In-house production

We aim to process articles as soon as possible. Authors will be informed of the production schedule and informed of any delays. Authors will need to be available to receive gallery proofs for approval.

We do not require authors to transfer copyright. Instead, authors are requested to sign and return a ‘licence to publish’ once an article has been accepted for publication (version of license will depend on open access option — see Author options post-acceptance). Authors can select the most suitable form from the list below.

Author options post-acceptance

Open Access

Authors of review articles are encouraged to submit the author’s version of the accepted paper (the unedited manuscript) to their funding body’s archive for public release six months after publication. In addition, authors are encouraged to archive this version of the manuscript in their institution’s repositories and on their personal websites six months after publication.

Authors of peer-reviewed articles can also opt to pay an article processing charge (in lieu of the standard publication charges) for their accepted articles to be open access online and freely accessible immediately upon publication. By paying this charge, authors are also permitted to post the final, published version of their article on a website, institutional repository or other free public server immediately on publication.

Open access articles can be published either under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International License, a Creative Commons Attribution-Noncommercial-Share Alike 4.0 International License, or a Creative Commons Attribution 4.0 International License at the free choice of the authors.

Pharmaceutical Journal Publications’ publishing policies ensure that authors can fully comply with the public access requirements of the major funding bodies worldwide (http://www.sherpa.ac.uk/romeo/journals.php?id=416&fIDnum=&mode=simple&letter=ALL). However, it is the author’s responsibility to take the necessary actions to achieve compliance. This may include self-archiving or choosing open access publication under the appropriate licence type choice.

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Site powered by Webvision